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A bstract: There is a great diversity o f the acute drugs overdose cases in clinical toxicology. Clinical situation 
is complicated by the coexistence o f factors predisposing to the development o f adverse drug reactions (chron­
ic use o f drugs, polypharmacy, alcohol or drugs dependence, nutritional disorders) and by the presence of 
chronic organ damage, especially the liver and the kidney. The aim o f this study w as to evaluate whether there 
are sensitive plasm a markers belonging to the antioxidant system in patients exposed to various xenobiotics.
W e measured the activity of antioxidant parameters: catalase (CAT), glutathione peroxidase (GPX3), glu­
tathione (GSH), sulfhydryl groups (-SH), carbonyl groups (=CO) and free radicals (2,2-diphenyl-1-picrylhy- 
drazyl, DPPH, assay) in serum of 49 patients with acute intoxication caused by carbamazepine (CBZ, n  = 9), 
m ixed drug intoxication (M DI) (n  = 9), alcohol withdrawal syndrome (AWS, n  = 9), acetaminophen (APAP, n 
= 7), tricyclic antidepressants (TCAs) (n = 5), valproic acids (VA, n  = 4), narcotics (N, n  = 3), and three others 
(benzodiazepines, BZD, n  = 2; barbiturates, n  = 1). The results were compared w ith the parameters o f not intox­
icated patients (n  = 39). All patients had lower catalase activity in com parison to the control group (41.9 ± 16.5 
vs. 196.0 ± 82.2 U /m g protein, p = 0.000), while the increase o f GSH level was particularly apparent only in 
patients with AWS (391.3 ± 257.9 pmol/mg protein) compared to the control group (171.4 ± 88.4 pmol/mg pro­
tein, p = 0.034) and to patients intoxicated with carbamazepine (152.8 ± 102.5 pmol/mg protein, p = 0.027).
Some differences, but w ithout statistical significance, were also observed in GPX3 activity between different 
groups o f poisoned patients.
K eyw ords: antioxidants defense, xenobiotics, enzyme activities
Most acute poisonings are due to single drug 
overdose but more and more often in clinical prac­
tice we observe multidrug poisonings, especially in 
patients with alcohol and drug addiction or with 
long pharmacological treatment of psychiatric dis­
eases. Clinical situation is complicated by complex 
interaction between toxic potential of the drug and 
coexistence of risk factors predisposing to the devel­
opment of drug toxicity and adverse drug reactions. 
Metabolism of xenobiotics takes place largely in the
liver, which accounts for the organ’s susceptibility 
to m etabolism-dependent, drug-induced injury. 
Drug metabolites can be electrophilic active chemi­
cals or free radicals that promote oxidative stress.
The metabolism of xenobiotics detoxification 
runs in two phases: phase I spans the reactions medi­
ated by cytochrome P450, and phase II comprises 
the conjugation of xenobiotics’ derivatives with 
organic and inorganic acids as well as with glycine 
and methionine. Biological sense of those reactions
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is primarily to increase the water solubility of xeno- 
biotics or their metabolites and to increase their 
elimination from the body in this way (1, 2). 
Detoxification processes do not always cause toxic­
ity reduction of xenobiotics, sometimes they can 
also increase toxicity, leading to the generation of 
reactive oxygen species (ROS), reactive nitrogen 
species (RNS) and/or alteration in antioxidant and 
the scavenging enzymes system. Both ROS and 
RNS can damage cellular organelles causing lipid 
peroxidation, and protein and DNA oxidation (2). 
W hether ROS and RNS activity has a causal or 
propagating role in human diseases associated with 
oxidative stress, remains an unresolved question. 
Moreover, even if the alteration of one or more bio­
markers of oxidative stress has been reported to 
occur virtually in all diseases, data on the 
oxidant/antioxidant balance in the course of poison­
ing are still extremely scarce (3).
We assume that severely poisoned patients 
could suffer from oxidative stress caused by ROS 
and RNS. Sources of ROS/RNS during poisoning 
include e.g.: production of the active metabolites 
including lipid hydroperoxides, singlet oxygen and 
hydrogen peroxide (1); adducts formations of the 
active metabolites with cellular proteins, lipids (2); 
the release of cytokines from immune cells, with 
subsequent activation of inflammatory cascades and 
an increase of the expression of adhesion molecules 
(3); severe hypotension with ischemia/reperfusion­
induced tissue damage (4-6). Inflammation and tis­
sue injury during poisoning result in an accumula­
tion of granulocytes in organs and lead to greater 
generation of ROS, which further perpetuates or 
increases the inflammatory response and tissue 
injury (7). Because of deep disturbance of con­
sciousness, respiratory failure and lung aspiration 
complications, poisoned patients frequently require 
the use of mechanical ventilation with high levels of 
oxygen for adequate brain and other vital organs 
oxygenation. Prolonged exposure to hyperoxia may 
also damage pulmonary epithelial cells with ROS 
stimulation. Taking into account ROS/RNS induc­
tion, poisoned patients should have reduced plasma 
and intracellular levels of antioxidants and free elec­
tron scavengers or cofactors, and decreased activity 
of the enzymatic system which is involved in ROS 
detoxification (8).
From a clinical point of view, it is important to 
search for biomarkers of ROS induction and, on the 
other hand, biomarkers indicating the consumption 
of the antioxidant system. The usefulness of an ideal 
biomarker of oxidative damage lies in its ability to 
provide a valid and early indication of disease
and/or its progression. We can use a number of 
assays which may be used to evaluate enzymatic and 
non-enzymatic defensive mechanisms which reduce 
harmful effects of ROS/RNS. Those antioxidative 
mechanisms may be considered as measures of bio­
logical response and adaptation. But selective meas­
urement of the antioxidant capacity does not provide 
relevant information on the overall antioxidant sta­
tus. Moreover, total antioxidant capacity is mani­
fested not only by concentration/activity of individ­
ual antioxidants but also by their synergistic action.
From a variety of oxidative/antioxidative 
parameters we selected for our study the following 
parameters: sulfhydryl groups (-SH), carbonyl 
groups (=CO), catalase (CAT), plasma glutathione 
peroxidase (GPX3), glutathione (GSH), free radicals 
(2,2-diphenyl-1-picrylhydrazyl, DPPH assay) in the 
blood serum. The major role of sulfhydryl groups 
lies also in stabilizing the three-dimensional struc­
ture of proteins, thereby preserving their functional 
properties. Sulfhydryls play an important role in 
biochemistry as disulfide bonds connect amino acids 
together for functional purpose in secondary, terti­
ary or quaternary protein structures. Sulfhydryl 
groups can be easily oxidized, and thiolates act as 
potent neucleophiles. Lipooxidation (LPO) and gly- 
cation processes lead to the formation of low molec­
ular mass reactive carbonyl species (RCO). 
Carbonyl compounds, like most other intermediates 
and by-products of metabolism, are electrophilic 
and thus, highly reactive when they meet different 
cellular nucleophilic groups (sulfhydryls, imida­
zoles and hydroxyls) as well as oxygen atoms of 
macromolecules such as proteins, nucleic acids and 
aminophospholipids, resulting in their nonenzymat- 
ic and irreversible modification, and formation of a 
variety of adducts and crosslinks collectively named 
ALEs (advanced lipoxidation end products) and 
AGEs (advanced glycation end products) (9-11). As 
the consequences of these effects, the disorders of 
the cellular metabolism and organelles may be 
observed. It was proposed to describe this process as 
“carbonyl stress” (12, 13). Therefore, at molecular 
level, carbonyl groups indicate chemical modifica­
tion of biomolecules and the extent of damage of the 
cellular structure and function.
The human antioxidant system is involved in 
the protection against ROS. It comprises enzymes 
such as superoxide dismutase (SOD), glutathione 
peroxidase (GPX), catalase (CAT) and nonenzymat- 
ic species, i.a., reduced glutathion, uric acid, creati­
nine. Other parameters such as sulfhydryl (-SH) or 
carbonyl (=CO) groups are indicators of damage 
caused by ROS. The first line of defense is formed
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by cytosolic and mitochondrial SODs which cat­
alyze the dismutation of superoxide anion radicals to 
hydrogen peroxide. Hydrogen peroxide is then 
removed by GPX or by CAT, found in the cytosol 
and mitochondria of most tissues.
Catalase activity becomes important at higher 
concentrations of hydrogen peroxide, at which the 
enzyme decomposes most of this compound to 
water and oxygen (14). Decreased CAT or GPX 
activity may lead to overproduction of superoxide 
and hydrogen peroxide which are substrates of the 
Fenton reaction leading to production of the most 
reactive oxygen radical -  the hydroxyl radical with 
oxidative damage of the cellular DNA, proteins and 
lipids.
Glutathione is the most abundant sulfhydryl- 
containing substance in cells. It can be oxidized to 
form a glutathione radical (GS*). Although GS* is a 
pro-oxidant radical, it can combine with another 
GS* to yield glutathione disulfide (GSSG) which is 
then reduced to GSH by the NADPH-dependent glu­
tathione reductase. GSH reacts with a variety of 
xenobiotic electrophilic compounds in the catalytic 
reaction of glutathione-S-transferase. GSH effec­
tively scavenges ROS like a lipid peroxyl radical, 
peroxynitrite and H2O2 directly and indirectly 
through enzymatic reactions. GSH can conjugate 
with NO, resulting in the formation of a S-nitroso- 
glutathione adduct which is cleaved by the thiore- 
doxin system to release GSH and NO. GSH interacts 
with sulfhydryl containing proteins which play 
important roles in the regulation of cellular redox 
homeostasis (15).
DPPH is a stable free radical and it is widely 
used to test the ability of antioxidants to act as free 
radical scavengers or hydrogen donors, and to eval­
uate total antioxidant activity of serum. DPPH has 
an odd electron which becomes paired with hydro­
gen from another free radical scavenging native 
antioxidant to form the reduced DPPH-H. The 
resulting decolorization of the serum specimen is 
stoichiometric with respect to the number of elec­
trons captured. The DPPH method is rapid and inex­
pensive, and it is not specific to any particular 
antioxidant component but applies to the overall 
antioxidant capacity of the sample.
The markers used in our study were chosen 
because of the simplicity of their measurement and 
because they appear to yield useful information on 
antioxidative system status. We measured several 
markers because the most accurate and clinically 
relevant approach to evaluating oxidative damage is 
to measure many different types of damage from 
different biomolecules. The aim of the study was to
investigate the influence of different xenobiotics on 
antioxidant parameters in serum of patients either 
exposed to various xenobiotics or with alcohol 
addiction, and to evaluate whether there are sensi­
tive plasma markers belonging to the response of the 
antioxidant system in such patients.
EXPERIMENTAL 
Patients
The patients (aged 17-80, mean 41 ± 15 years) 
included in the study group were hospitalized 
because of acute intoxications by carbamazepine (n 
= 9), mixed drug intoxication (MDI) (n = 9), alcohol 
withdrawal syndrome (AWS, n = 9), acetaminophen 
(APAP, n = 7), tricyclic antidepressants (TCAs) (n = 
5), valproic acids (VA, n = 4), narcotics (N, n = 3) 
and three others (benzodiazepines, BZD, n = 2; bar­
biturates, n = 1). Serum and urine from patients was 
frozen after collection at -8 0 OC until analysis.
The studies were conducted with approval of 
Bioethical Commission of Jagiellonian University 
(KBET/108/B/2011 30. 06. 2011).
All patients were symptomatic and routine bio­
chemical analysis of the blood samples (total biliru­
bin, alanine aminotransferase, aspartate aminotrans­
ferase, y-glutamyl transpeptidase, international nor­
malized ratio, urea, creatinine, creatine phosphoki- 
nase) was conducted for each patient to diagnose the 
organ damage (i.e., liver, kidney, muscles). Acute 
poisoning was diagnosed based on history, clinical 
symptoms and confirmation of the presence in 
serum or urine of at least one of the following xeno- 
biotics: carbamazepine, ethanol, acetaminophen, tri­
cyclic antidepressants, valproic acids, benzodi­
azepines, phenobarbital, salicylates, phenothiazines, 
amlodipine, baclofen, dextromethorphan, metopro­
lol, m ianserine, propaphenon or zolpidem. 
Additionally, alcohol dependence was diagnosed 
based on psychological tests. The control group was 
recruited among healthy volunteers aged 15-76, 
mean 43 ± 20 (n = 39).
Methods
Antioxidant parameters: catalase was measured 
by the Aebie method (16), -SH groups by the Hu 
method (17), =CO groups by the Levine method (18) 
and glutathione peroxidase by the Paglia and Valentine 
method (19). Percentage of inhibition (%) of free radi­
cals was measured using the DPPH test (20).
Statistical approach
Mean values and standard deviations were cal­
culated for all antioxidant parameters. The differ-
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ences between groups were checked using the 
ANOVA test with the Tukey post hoc test. The 
homogeneity of variances were tested by 
means of the Levene’s test. In case of non- 
homogenous variances, the Welch test was 
applied to compare groups with different diag­
nosis. Spearman’s correlation coefficients were 
calculated for all pairs of parameters, separate­
ly in groups of patients and controls. The Fisher 
two-tailed test was used to assess the signifi­
cance of the difference between two Spearman 
correlation coefficients.
A probability level of p < 0.05 was con­
sidered to be statistically significant. Principal 
Component Analysis (PCA) was used in order 
to reveal possible differences or similarities 
between the patients and the controls in multi­
dimensional space established by the whole set 
of investigated parameters. Before using this 
method, the variables had been standardized. 
Statistical calculations were carried out using 
the commercially available packages: SPSS 
Statistics 22 (IBM) and Statistica PL v.10 
(StatSoft).
RESULTS
The descriptive statistics and a compari­
son of antioxidant parameters in the study and 
control groups were detailed in Table 1. All 
patients with diagnosed acute xenobiotics poi­
soning and the patients with alcohol withdraw­
al syndrome had statistically significant lower 
catalase activity in comparison to the control 
group (41.9 ± 16.5 vs. 196.0 ± 82.2 U/mg, p = 
0.000). The patients with AWS had higher 
GSH levels (391.3 ± 257.9 pmol/mg) compared 
to the control group (171.4 ± 88.4 pmol/mg, p 
= 0.034) or to the patients intoxicated with car- 
bamazepine (152.8 ± 102.5 pmol/mg, p = 
0.027).
We did not find any other differences 
between the studied groups and controls. The 
first three principal components (PC) of the 
PCA model, w ith respective eigenvalues
1.49, 1.22 and 1.09, explained 63.1% of total 
variance of the original parameters. The first 
PC was loaded mainly by GSH and GPX3 
(positively , w ith corresponding w eights:
0.778, 0.747) and % inhibit (negatively, with 
weight = -0.438), while the second (i.e., ver­
tical) PC was loaded predom inantly by CAT 
(weight = 0.615) and =CO (weight = 0.591). 
Figure 1 shows patients and controls scores
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in the space established by the first two principal 
components of the PCA model. Spearman rank 
correlation coefficients, calculated separately for 
the patients and the controls, and the significance 
of the difference between them are shown in 
Table 2.
DISCUSSION
The literature referring to the ROS studies is 
enormous. The studies are performed using avail­
able analytical methods and there are no “gold stan­
dard” assays of free radical activity (15, 21). 
Several approaches such as determ ination of 
endogenous antioxidant levels, measurement of the 
products of oxidized macromolecules and direct 
detection of free radicals are most often used. To 
assess endogenous antioxidant capacity, we exam­
ined the concentrations of antioxidants like GSH
and the activity of antioxidant enzymes like CAT 
and GPX3 in plasma.
GSH is rapidly oxidized to GSSG by radicals 
and other reactive species and then GSSG is export­
ed from cells to the blood; thus, it can provide a 
valid marker of oxidative stress. To assess ROS- 
induced protein and lipid oxidation, we determined 
the production of carbonyl groups and the loss of 
free sulfhydryl groups, while DPPH was used as a 
marker of the overall antioxidant capacity.
On the other hand, there is a great diversity of 
the cases of acute drug overdoses, admitted to the 
toxicology department. Clinical situation is frequent­
ly complicated by the coexistence of risk factors pre­
disposing to the development of adverse drug reac­
tions and drug toxicity. Those involve a complex 
interaction between toxic potential of the drugs (e.g., 
reactive metabolites, free radical generation, mito­
chondrial effects), environmental factors (e.g., con­
- 5 - 4 - 3 - 2 - 1 0  1 2 3 4
First Principal Component
Figure 1. Patients and controls scores in the space established by first two principal components of the PCA model.
Table 2. Spearman rank correlation coefficients for patients and controls (p < 0.05), and the significance of the 
difference between them (NS -  not significant).
Pairs o f correlated parameters Patients Controls p
CAT and =CO -0.323 NS -
CAT and % inhibit. 0.317 -0.388 0.001
=CO and % inhibit. -0.302 NS -
GPX3 and GSH NS 0.500 -
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comitant drugs or alcohol use), patient-related fac­
tors (e.g., age, gender, underlying diseases, co-med­
ications, nutritional status, activation of the immune 
system, physical activity) and genetic factors e.g., 
genetic polymorphisms of genes controlling drug 
metabolism, detoxification, transport. (1, 2, 22-25). 
Under physiologic conditions, approximately 1 to 
3% of the oxygen consumed by the body is convert­
ed into superoxide and other ROS (26). In the course 
of acute poisoning or chronic drug or ethanol abuse, 
any person may be at a risk of oxidative stress 
induced by high rates of oxygen usage (e.g., agita­
tion, respiratory and cardiac failure, hyperthermia). 
Prolonged exposure to free radicals, even at low con­
centrations, may result in the damage of biologically 
important molecules and potentially lead to DNA 
mutation, tissue injury and disease (27, 28).
Many of the acutely drug poisoned patients 
and with alcohol addiction chronically use 
antiepileptic, antidepressant or antipsychotic drugs. 
It has been reported that long treatment by some 
antiepileptic drugs (carbamazepine, valproic acids, 
barbiturates) and tricyclic antidepressant drugs can 
induce oxidative stress in tissues and organs and 
lead to their injury. This is reflected by higher lipid 
peroxidation, protein carbonyl levels, an oxidized 
glutathione level and inhibition of antioxidant 
enzymes activities including CAT and GPX (29­
32). According to the literature data, CAT activa­
tion occurs in a short time (30-60 s.) due to high 
levels of hydrogen peroxide which arise after acute 
or chronic exposition to a ROS generating agent 
(e.g., drug or ethanol overdose). This process may 
lead to impairment of antioxidant defense manifest­
ed in the final fall of CAT activity much below the 
value observed in the control group, which was also 
observed in our study.
It can be assumed that the reduced CAT activ­
ity is due to its increased consumption as a result of 
an excess of the formed hydrogen peroxide, or the 
lack of CAT activation due to a decreased CAT’s 
substrate level. Another factor contributing to the 
reduced serum CAT activity may be the time period 
between the xenobiotics overdose and the collection 
of blood samples, as in clinical practice acutely poi­
soned patients are admitted to the toxicology depart­
ment usually more than one hour after the drugs 
overdose.
On the other hand, we did not observe any sta­
tistically significant differences between the patients 
poisoned due to GPX3 activity. GPX3 activity is 
known also as a marker of oxidative stress vulnera­
bility (33). Intrinsic GPX3 activity is important, 
because this enzyme, like CAT, converts hydrogen
peroxide to water with simultaneous oxidation of 
reduced GSH to its oxidized form, GSSG. Our 
results suggest that hydrogen peroxide transforma­
tion involving GPX3 has less significance than CAT 
in the case of acute poisonings.
We found statistically significant increased 
GSH levels in the patients with AWS compared to 
the control group and to the patients intoxicated 
with carbamazepine. We did not observe signifi­
cant GSH depletion in any group of patients, even 
in the case of malnourished patients with alcohol 
dependence, psychiatric diseases and with recog­
nized alcoholic liver disease with increased serum 
transaminase activity. This stands in conflict with 
other data that confirmed the glutathione role as 
one of the most important endogenous antioxidants 
in the cell (34-36). A ROS attack may lead to a 
major depletion of reduced glutathione, and after 
GSH depletion the toxicity of ethanol is strikingly 
enhanced (37-39). At the moment, we cannot 
explain the dissociation between our experimental 
data and the results of other authors. Future studies 
of both reduced and oxidized glutathione and glu- 
tathionylated proteins (PSSG), and their relative 
ratios in human plasma may give fundamental 
information on the intracellular redox status of the 
whole organism and be useful quantitative sys­
temic biomarkers of oxidative stress and disease 
risk, and may also provide essential parameters to 
link environmental influences and progression of 
changes associated with alcohol dependence (3, 
40-43).
In the case of acute ethanol intoxication, main 
ethanol metabolism is related to alcohol dehydroge­
nase (ADH). Chronic ethanol consumption causes 
also induction of the cytochrome P450-dependent 
formation of reactive metabolites that cause direct 
toxicity, with lipid and protein peroxidation leading 
to phospholipids changes in cell membranes, an 
increased level of protein carbonyls, decreased 
sulfhydryl groups, and glutathione depletion (34, 35, 
44, 45). The third ethanol metabolism pathway con­
nected with CAT activity is less important. In our 
study, we noted significantly decreased CAT activi­
ty in the alcohol addicted group, while no changes in 
the carbonyls and sulfhydryl groups level were 
observed.
It is known that acetaminophen initial hepato- 
toxicity leads to synthesis of active metabolite, N- 
acetyl-p-benzoquinone imine (NAPQI). NAPQI 
reacts with hepatic GSH leading to its depletion. 
Additionally, NAPQI covalently binds to sulfhydryl 
groups of proteins as acetaminophen-cysteine 
adducts (46). It is worth underlining that because of
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specific antidotal treatment (e.g., with N-acetylcys- 
teine) used to protect the patients against hepatotox- 
icity, all those patients who received such treatment 
before admission to the toxicology department we 
excluded from our study.
According to the acetaminophen hepatotoxici- 
ty mechanism, one should suspect a decreased GSH 
level in the case of severe acute acetaminophen poi­
soning. However, it is important to note that all 
patients within the acetaminophen overdose group 
were so far healthy young people. All of them were 
admitted to hospital during the first 24 h after the 
acetaminophen overdose. In this time period, not all 
the acetaminophen dose was metabolized (acetamin­
ophen was still present in the blood) and this is a 
possible reason why we did not observe significant 
GSH depletion.
Some differences in the scatter of patients and 
controls can be observed in the PCA plot. Namely, 
almost all patient were localized in a lower cluster 
(Fig. 1). As the second (vertical) principal compo­
nent was mainly influenced by CAT (and to a lesser 
degree by PCO), such a result confirms our finding 
that CAT can be a particularly sensitive parameter in 
diagnosing the onset and progression of acute poi­
soning. Both groups differed also in correlations 
between some parameters (Table 2) which appeared 
in one group but not in the other. Most striking is the 
difference for the correlation between CAT and % 
inhibition, as it was positive in the patients and neg­
ative in the controls. The physiological meaning of 
such differences should be clarified in future stud­
ies.
CONCLUSIONS
The presented results confirm the significantly 
reduced CAT activity in all patients with acute drugs 
poisoning and with alcohol addiction. Oxidant/ 
antioxidant imbalances occurring under the influ­
ence of acute or chronic exposition to xenobiotics 
may cause temporary or fixed dysfunction of bio­
logical systems.
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